The Fas death receptor is a cell surface molecule involved in apoptosis as well as in proliferative or activating signals of many cells types, including T lymphocytes. Using quantitative real-time reverse transcription-PCR analysis, we confirm that expression of this gene is scarcely perceptible in thymic lymphomas induced by c-irradiation in C57BL/6J mice. Notably, we also demonstrate for the first time that Fas expression is significantly upregulated in vivo both after single high dose of radiation and in thymic lymphoma-free mice. In addition, we determined its levels of expression in five mouse strains exhibiting different degrees of susceptibility (SPRET/Ei, SEG/Pas, BALB/cJ, C57BL/6J and RF/J). Interestingly, we found the highest levels of expression in SPRET/Ei and SEG/ Pas strains (both derived from the Mus spretus species), which are known to have the most resistant phenotype, and the lowest levels in the most susceptible strains C57BL/6J and RF/J. DNA sequencing of the Fas promoter in all five strains showed many polymorphisms that can be classified into three functional haplotypes by using luciferase assays: (1) C57BL/6J and RF/J, (2) BALB/cJ and (3) SPRET/Ei and SEG/Pas. Promoter activities in response to single high doses of radiation correlated well with the levels of Fas expression and are consistent with the degree of strain susceptibility.
Introduction
The Fas gene (also known as Apo-1 or CD95) is a death domain-containing member of the tumour necrosis factor receptor (TNFR) superfamily. Binding of this gene product to its ligand (Fas-L) triggers apoptosis involved in the removal of autoreactive lymphocytes during normal development in the immune system. The Fas/ Fas-ligand system can also transduce proliferative or activating signals (Siegel et al., 2000) . Consistent with these functions, alterations in the Fas/Fas-ligand system have been implicated in the pathogenesis of many tumour types as well as in some diseases of the immune system (Krammer, 2000) .
While there is no doubt that Fas may regulate peripheral lymphoid apoptosis or activation, there exist conflicting results regarding its role in thymocyte development (Rathmell and Thompson, 2002) . Favouring the hypothesis of a role for Fas in thymocyte development, several independent papers have provided evidence for the involvement of Fas/Fas-ligand interaction in negative and/or positive selection of thymocytes during early thymic development in gestation and in negative selection of thymocytes in adult mice depending on the dose of the antigen Fleck et al., 1998; Kishimoto et al., 1998; Kurasawa et al., 1999) . Still, in peripheral T cells, stress from ionizing radiation exposure has been shown to lead to Fas/Fas-L activation and subsequent apoptosis (Reap et al., 1997; Booker et al., 1998; Pinkoski and Green, 1999) , although the role of this system in eliminating thymocytes inside the thymus of irradiated mice remains elusive.
In a previous paper, we demonstrated that mouse thymic lymphomas induced by g-irradiation expressed lower levels of Fas mRNA than those found in control thymuses, suggesting that a silencing of this gene may contribute to the development of such tumours (Santos et al., 2001 ). In addition, using a panel of interspecific chromosome substitution strains between Mus spretus (SEG/Pas) and C57BL/6J, we have recently identified a thymic lymphoma-resistance locus (Tlyr1) on chromosome 19 that includes Fas as a putative candidate gene for tumour resistance (Santos et al., 2002) . Within such a context, it is worth noting that the risk of developing acute myeloid leukaemia (AML) has been associated with a polymorphism in the human FAS promoter, which affects an SP1-binding site (Sibley et al., 2003) .
Keeping in mind these considerations, the aim of the present paper was initially to analyse the levels of transcriptional gene expression of Fas in thymuses from C57BL/6J mice treated with different doses of g-radiation to assess the implication of the Fas/Fas-L system in both the response of thymocytes to damage caused by radiation and thymic lymphoma development. Afterwards, we performed an analysis of Fas expression with thymuses from five mouse inbred strains exhibiting differences in their degree of susceptibility to g-radiation-induced thymic lymphomas. Our results revealed a significant in vivo increase of Fas mRNA expression in thymuses after single high doses of g-irradiation and thymuses of mice that did not develop the tumour after four weekly sublethal doses of radiation, together with a significant decrease in thymic lymphomas. Remarkably significant differences between thymus expression levels of strains showing differential susceptibility to tumour induction were detected. Sequencing of the Fas promoter in these strains evidenced many polymorphisms that allowed us to define three functional haplotypes through luciferase assays. Interestingly, we observed a correlation between the increase of the promoter activity and the diminishing susceptibility of mouse strains. These results are discussed in relation to the possible involvement of allele Fas variants in modulating the phenotypes of resistance/susceptibility to g-radiation-induced thymic lymphomas in mouse inbred strains.
Results

Transcriptional expression analysis of Fas in the thymus
Sets of 30 individuals from the C57BL/6J, RF/J, BALB/ cJ, SPRET/Ei and SEG/Pas mouse strains were taken for this work. Of these, five mice from each strain were treated with lethal doses of radiation (10 Gy), the remaining individuals being subjected to four weekly sublethal doses (1.75 Gy). In addition, mRNA samples from lymphomas previously induced in SPRET/Ei and SEG/Pas strains were incorporated. We have studied the levels of in vivo expression of the Fas gene through quantitative real-time reverse transcription-PCR (RT-PCR) in thymuses from mice treated with lethal doses as well as in thymuses from thymic lymphoma-free and thymic lymphoma-bearing mice treated with sublethal doses of g-irradiation. The results obtained from the C57BL/6J strain revealed that Fas expression is nearly absent in 13 out of the 13 thymic lymphomas (Figure 1) , confirming previous data. Conversely, we found a significant increase in the expression in thymuses of mice 24 h after treatment with single high doses and those from tumour-free mice treated with four sublethal doses and left for a latency period of 25 weeks (Figure 1 ). It appears then that g-radiation triggers an in vivo Fas expression inside the thymus possibly as part of a defensive response of the damaged thymocytes. The comparison of the patterns of expression in thymuses from the aforementioned strains allows one to classify them into three groups (Figure 2 ). The one consisting of the SPRET/Ei and SEG/Pas strains exhibited the highest levels of basal expression (mean-normalized value 1.6740, s.e. 0.03295), whereas the BALB/cJ group presented intermediate values (mean 1.2480, s.e. 0.009695) and the C57BL/6J and RF/J group showed the lowest ones (mean 0.9240, s.e. 0.03906). With regard to treatments with lethal single doses of radiation, Fas expression experienced a considerable increase compared to the basal values, and similar differences among the three groups of strains were observed. Once again, the SPRET/Ei group was the one exhibiting the highest levels (mean normalized value 7.61, s.e. 0.2740), whereas the BALB/cJ group had intermediate values (mean 6.39, s.e. 0.2979 ) and the C57BL/6J group showed the lowest ones (mean 3.61, s.e. 0.3527). All data represent an average of two independent experiments, each of them performed in triplicate. A one-way ANOVA and a Tukey comparison post test evidence significant differences among the three groups (Po0.001). Interestingly, 
Polymorphisms at the Fas promoter regions
To determine whether these differences in the levels of expression could be attributed to variations in the promoter region, the promoters of all the strains were sequenced (GenBank Accession numbers: C57BL/6J: DQ003592; BALB/cJ:DQ003593; RF/J:DQ003594; SPRET/Ei:DQ003597; SEG/Pas:DQ003598) and compared with the sequence published for 129/svJ (Zheng et al., 2001) . The promoter sequence of C57BL/6J is identical to that of 129/svJ, although a considerable number of nucleotide variations among the promoters of the five analysed strains was detected that allowed their classification into haplotype groups previously defined by the expression analysis: (1) C57BL/6J and RF/J, (2) BALB/cJ and (3) SPRET/Ei and SEG/Pas (Figure 3 ). Using the haplotype of the C57BL/6J group as the reference, the promoter of BALB/cJ exhibited a major or critical nucleotide substitution located within a transcription factor-binding site AP1 (À375 A/G), whereas the promoter of the SPRET/Ei and SEG/Pas exhibited two major variants affecting the transcription factor-binding sites NF-AT (À964C/T) and NF-kB (À598Ins. C).
Sequence variants at Fas promoters involve functional polymorphisms
Having demonstrated significant differences among the DNA sequence of promoters from three groups of strains, we sought to probe the functionality of these variants (haplotypes) through Luciferase assays using PMA/Ionophore activation of JK cells. However, since our in vivo model consists of g-radiation-induced thymic lymphomas, we also determined the level of Luciferase activity after Fas promoter activation using a single high dose of g-irradiation. To this end, we selected a 10 Gy treatment since this has been reported to be an apoptosis-inducing dose (Maas et al., 2005) . In order to establish the optimal incubation time point, Luciferase activity was measured in cells treated with 10 Gy g-irradiation and then incubated for 4, 6, 8, 10 and 24 h. The time course experiment described a curve in which activation was maximal at 10 h (data not shown).
C57BL/6J and RF/J Fas promoters drove Luciferase transcription to either a 25.11-fold increase (PMA/ Ionophore-activated JK cells) with respect to the empty plasmid in nonactivated cells (pGL2-NA) or a 5.34-fold increase in the case of g-radiation-activated JK cells. The SPRET/Ei and SEG/Pas promoters on the other hand provided values of either 34.51-fold increase (for PMA/ Ionophore-activated JK cells) or a 8.32-fold increase in the case of g-radiation-activated JK cells. Finally, the promoter of BALB/cJ exhibited an intermediate increase of either 28.27-fold (for PMA/Ionophoreactivated JK cells) or 6.96-fold in the case of g-radiation-activated JK cells (Figure 4 ). In both cases (PMA/Ionophore-and g-radiation-activated JK cells), a one-way ANOVA test revealed significant differences between the groups (P ¼ 0.007 and 0.005, respectively). All these results can be considered valid given that in all cases promoter activities exhibit greater than twofold increase over the basic promoterless vector (Hoogendoorn et al., 2003) . Data are the average for three different assays. In order to enhance comparisons, the normalized reporter activity for each promoter (Luciferase value/Renilla value) was referred to that of C57BL/6J ( Figure 5 ). Interestingly, there does seem to exist a significant correlation between the promoter activities and the levels of mRNA Fas expression (r ¼ 0.923 with a Po0.001 when PMA/Ionophoreactivated, and r ¼ 0.717 with a P ¼ 0.003 when g-radiationactivated JK cells).
Discussion
The Fas/Fas ligand system mediates apoptosis as well as the proliferative or activating signals that appear to be central in the regulation of peripheral tolerance (Chan et al., 1999; Siegel et al., 2000) . Mutations in either the receptor or its ligand may induce lymphadenopaty and autoimmune diseases caused by defects in activationinduced cell death (AICD) and peripheral T-and B-cell deletion (Krammer, 2000; Rathmell and Thompson, 2002) . With regard to cancer, broad evidence reveals 
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that the susceptibility of certain tumour cells might be attributed to a reduction of their Fas/Fas ligandmediated apoptosis. In humans, both germline and somatic mutations of the Fas gene have been associated with an increased risk of both lymphoid and solid tumours (Muschen et al., 2000) . In a previous paper, we reported that the expression of Fas is scarcely perceptible in g-radiation-induced thymic lymphomas in the susceptible mouse strains C57BL/6J and BALB/cJ (Santos et al., 2001 ). In addition, we evidenced the existence of a thymic lymphoma-resistance locus (Tlyr-1) on chromosome 19 in a region containing Fas as a putative candidate modifier gene (Santos et al., 2002) . To assess whether Fas is involved in g-radiation-induced susceptibility to thymic lymphomas, we analysed the in vivo pattern of transcriptional expression of this gene through quantitative real-time RT-PCR in thymuses from mice treated either with single high doses or four sublethal doses of radiation. As expected, Fas expression is essentially absent in thymic lymphomas, suggesting that such a reduction may favour the development of thymic lymphomas. Remarkably, we likewise detected an in vivo overexpression in the early and late response to radiation. This increase after treatment with g-irradiation includes both immature thymocytes that other authors described in splenic T cells from treated mice and cell suspensions of peripheral T cells irradiated in test tubes (Reap et al., 1997; Booker et al., 1998; Pinkoski and Green, 1999; Siegel et al., 2000) . This suggests that the Fas/Fas ligand system might also be critical in eliminating damaged cells within the thymus after g-radiation treatments. In addition, the overexpression of Fas after the period of latency (i.e., long after the radiation treatment) could be attributed to some kind of epigenetic mechanism and extends the importance of the Fas/Fas ligand system to maintain a phenotype of resistance in more advanced stages of tumour development. Tumours develop multiple mechanisms to evade the immune response, deletions of antitumour lymphocytes by Fas expression being one of them (Krammer, 2000; Sibley et al., 2003) . However, there exist conflicting results on the role played by Fas in thymocyte development. Although several papers proposed that Fas is not required for thymic selection Adachi et al., 1996) , other studies appear to demonstrate that Fas is expressed by immature thymocytes (Nishimura et al., 1995; Ogasawara et al., 1995) and highlight the importance of Fas in the control of negative selection of such cells Fleck et al., 1998; Kishimoto et al., 1998; Kurasawa et al., 1999) . Given that we detected an overexpression of Fas in those thymuses that resisted to be transformed and an absence of Fas in thymic lymphomas, our data clearly stress the critical role of Fas signalling in protecting against tumorigenesis.
In order to assess whether Fas might play a role as a germline modulator of resistance/susceptibility, we studied the patterns of expression in a panel of five mouse strains exhibiting differences in their degree of resistance/susceptibility to the development of g-radiation-induced thymic lymphomas. Interestingly, we found that the highest levels of expression occurred in the extremely resistant strains SPRET/Ei and SEG/ Pas, and the lowest levels in the most susceptible strains C57BL/6J and RF/J. In addition, the strain BALB/cJ, which exhibited an intermediate degree of susceptibility, also showed an intermediate level of transcription.
Since there are several reports in humans suggesting an association between polymorphisms in the Fas promoter and the risk of developing several diseases including neoplasic processes (Feuk et al., 2003; Lai et al., 2003; Sibley et al., 2003) , we decided to analyse the promoter sequence of the five strains and to explore their functionality through luciferase assays. We detected many polymorphisms distributed along the entire Figure 5 Comparison between Fas promoter activity and Fas transcriptional expression level. Fas promoter activity in activated Jurkat T cells is expressed as the ratio (normalized reporter activity of each promoter/normalized reporter activity of C57BL/6J). Normalized reporter activity is calculated as the ratio (Firefly luciferase value/Renilla luciferase value). JK cells were either treated with PMA/Ionophore or with g-radiation. Fas transcriptional expression level is normalized using C57BL/6J as a calibrator.
MOUSE STRAINS
Functional polymorphisms of Fas and thymic lymphomas M Villa-Morales et al promoter region, some of them affecting critical transcriptional factor sites. Sequencing data allowed us to classify the promoters of the five strains into three different haplotypes that also exhibited significant differences in their promoter activity. Remarkably, the differential response of the promoters to single high doses of radiation supports the hypothesis that Fas promoters differences are responsible (at least in part) for the recorded differences in the radiation-induced expression of this gene. A linear regression analysis revealed a clear association between promoter activities and levels of transcriptional expression of Fas, indicating that the structural differences detected among the promoters clearly contribute to the pattern of differential expression of Fas in these strains. It may be useful to stress that the expression of Fas is extremely low in g-radiation thymic lymphomas regardless of strain susceptibility, confirming that this reduction should be a necessary step in order to attain the tumour phenotype. Furthermore, since thymic lymphomas from all strains retain similar low levels of Fas expression (i.e. there do not exist significant differences among Fas expression levels in thymic lymphomas from the three groups of strains), we suggest the existence of a common 'tumour-threshold' of Fas expression below which any thymus may develop into a thymic lymphoma. If this were so, it would be reasonable to assume that thymic lymphomas would be more frequent in those strains that exhibit a lower basal and radiation-induced levels of expression ('susceptible' strains) compared to those exhibiting higher levels ('resistant' strains).
As mentioned, the promoter of mouse strains C57BL/ 6J and RF/J exhibits the lowest luciferase activity. Since the promoter of BALB/cJ differs from that of C57BL/6J only in a base substitution affecting a transcription binding site (AP1) (Figure 3) , it is reasonable to think that this alteration should be responsible for the intermediate level of promoter activity observed in this strain. Such phenomenon could possibly occur by altering the affinity of binding to DNA of some transcription factors such as Jun and/or Fos. Interestingly, c-fos is a transcription factor overexpressed during negative selection inside the thymus (DeRyckere et al., 2003; Schmitz et al., 2003) and the c-Jun N-terminal kinase (JNK) pathway also appears to play an important role in this selection (DeRyckere et al., 2003) . Finally, the promoter of the M. spretus group (SPRET/Ei and SEG/Pas) that exhibited the highest level of luciferase activity differs from that of C57BL/6J by two major modifications located at two critical sites (NF-kB and NF-AT sites) that are known to be important for the transcriptional regulation of the human and mouse Fas promoters and have been involved in the generation and survival of thymocytes as well as in apoptosis within the thymus (Oukka et al., 1998; Chan et al., 1999; Hettmann et al., 1999; Hettmann and Leiden, 2000; Zheng et al., 2001) .
Taken together, all these findings indicate that there exist several promoter polymorphisms between the different mouse strains that define three groups of functional alleles exhibiting different degrees of Fas mRNA expression in response to g-irradiation. It is further suggested that these Fas variants might be involved in modulating the resistance/susceptibility phenotype of mice to g-radiation-induced thymic lymphomas. However, further studies are needed in order to confirm this last suggestion. Since Fas is a receptor protein that acts in conjunction with its ligand (FasL), and intriguing differences between the sequence of FasL in different mouse strains (Reap et al., 1997) have been reported, additional in vivo or in vitro studies based on the simultaneous manipulation of both genes will be required.
Materials and methods
Mice and treatments
Mice from the strains C57BL/6J, RF/J, BALB/cJ and SPRET/ Ei were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). SEG/Pas was provided by Dr JL Guenet (Institute Pasteur, Paris). A fraction of the adult mice (35-65 days) were treated with lethal single high dose of g-irradiation (10 Gy) and killed 24 h later. Other mice were subjected to whole body g-irradiation split into four weekly sublethal doses of 1.75 Gy. Thymic lymphomas were observed to develop at regular intervals of 25 weeks following treatment and were characterized as has been previously described (Santos et al., 2002) . In our experimental conditions, the strains C57BL/6J and RF/J (both derived from M. musculus) exhibited a global incidence of 73.4% (Santos et al., 1996) . In contrast, SPRET/Ei and SEG/Pas, both derived from M. spretus, are extremely resistant with a tumour incidence of only 3% (Santos et al., 2002) . As far as the BALB/cJ strain, also derived from M. musculus, is concerned, an intermediate incidence of tumours of around 60% was detected (Mele´ndez et al., 1999) . For animal experimentation, we followed the ethical considerations available from the European Commission (Directive 86/609/ CEE) for the humane care and use of laboratory animals.
Quantitative RT-PCR RNA from the thymus was obtained using Tripure reagent (Roche, Mannheim, Germany). The determination of the transcript levels was performed by quantification assays on the basis of real-time RT-PCR with a LightCycler instrument (Roche Diagnostic, Penzberg, Germany) using fluorescenceresonance energy-transfer (FRET) hybridization methodology. The gene encoding the tubulin beta 5 chain (Tubb5) was used as an internal control of the RNA quality and amplification. Primers and FRET probes were as follows: mFas-f: 5 0 -CGCC CGCTGTTTTCCCTT-3 0 ; mFas-r: 5 0 -AGCAAAATGGGCC TCCTTG-3 0 ; mFas-FL: 5 0 -TTAACTGTGAGCCAGCAAGC ACCAGA-3 0 ; mFas-LC: 5 0 -CAGGACAGCCCAGATCCAC AGCAT-3 0 ; Tubb5-f: 5 0 -TGGGACTATGGACTCCGTTC-3 0 ; Tubb5-r: 5 0 -GTGGGTCAGCTGAAAGCCT-3 0 ; Tubb5-FL: 5 0 -GGCCTTTAGCCCAGTTGTTGCCT-3 0 ; Tubb5-LC: 5 0 -CC CCAGACTGACCGAAAACGAAGTT-3 0 . The hybridization probes were designed by TibMolBiol (Berlin, Germany). Reactions for real-time PCR were performed using the one-step LightCycler kit (Roche). In all, 400 ng of total cellular RNA from each thymus sample were used to generate cDNA in a reaction containing 3.25 mM of Mn(OAc) 2 , 0.5 mM of each primer, 0.2 mM of each probe and 1 Â LC RNA Master Hybridization Probes mix (Roche). The cDNAs of Fas and Tubb5 were subsequently coamplified using the following PCR conditions: 951C for 2 min followed by 40 cycles with 951C for 10 s, 551C for 30 s and 721C for 15 s. All PCR reactions were repeated for each sample in three independent experiments. Fas expression levels were calculated with the LightCycler Relative Quantification software (Roche).
Genotyping of the mouse Fas promoters DNA from the thymus was extracted using DNAzol reagent (Molecular Research Center, Inc., Cincinnati, OH, USA). Based on the sequence of the 129/svJ Fas promoter, reported in 2001 (Zheng et al., 2001 ; GenBank accession number AY027814), three overlapping primer pairs for the PCR ampli- 0 . With these primers, three fragments of 415, 426 and 495 bp comprising from nucleotide À1272 to the translational start site (not included) were amplified. PCR products were electrophoresed in 1% agarose gels containing ethidium bromide. DNA extracted from agarose gel bands was purified using QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany), then sequenced on an ABI Prism 310 Automated Sequencer (Applied Biosystems). A comparison between the sequences thus obtained and those previously reported for the promoter of 129/svJ (Zheng et al., 2001) was made using the program L-Align from ExPASy Molecular Biology Server.
Cloning of the Fas promoters and reporter constructs A couple of primers for amplifying the Fas promoter containing two distinct restriction sites for KpnI and XhoI were designed. These enzymes do not cut inside the Fas promoter region and are included in the multiple cloning site of pGL2-Basic plasmid (Promega, Madison, WI, USA). The sequences of these primers are as follows (generated restriction sites underlined): FasPromKX-F: 5 0 ATCTTCCGGTACCAAAGA TGTTGGCAT 3 0 ; FasPromKX-R: 5 0 ATGTCTGCAGCTCG AGAAAACAGCG 3 0 . Using the Expand High Fidelity PCR System (Roche Diagnostic, Germany) and the aforementioned primers, a fragment containing the Fas promoter and part of exon 1, from nucleotide À1272 to the translational start site, was amplified. The PCR products were electrophoresed in 1% agarose gel containing ethidium bromide and purified using a QIAquick Gel Extraction Kit (Qiagen). Finally, fragments were doubly digested with KpnI and XhoI (Roche Diagnostic, Germany) and cloned into pGL2-Basic.
Cell culture, transient transfections and luciferase assays Jurkat T cells were cultured in RPMI supplemented with 10% FBS, penicillin (100 mg/ml), streptomycin (100 U/ml), HEPES (10 mM), L-glutamine (2 mM) (Gibco, Carlsbad, CA, USA), sodium pyruvate (1 mM) and MEM nonessential amino acids 1 Â (Biowhittaker, Cambrex Corporation, East Rutherford, New Jersey, USA). Transfections were performed using Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA, USA). At 24 h after transfection, cells were either assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega) or activated either with PMA (100 ng/ml, Sigma, St. Louis, MO, USA) and calcium ionophore (1 mM, Sigma) for 6 h before assaying for luciferase activity, or with a 10 Gy-g radiation treatment (10 6 cells/ml PBS) for ten hours before assaying for luciferase activity. For normalization, the pRL-tk Renilla Normalizing Luciferase Vector (Promega), cotransfected with pGL2 constructs, was used. Both Firefly and Renilla luciferase activities were monitored using a Sirius luminometer (Berthold, Germany).
Statistical methods
The Kolmogorov-Smirnov test was used to check the data sets for normality, and Levene's test was used to test for homogeneity of variances. Statistical significances were determined using a one-way ANOVA with a Tukey comparison post test. All statistical tests were done using SPSS software (SPSS Inc., version 12.0, Chicago, IL, USA).
